As of November 2024, Wakamoto Pharmaceutical has a market cap of $59.12M. This makes Wakamoto Pharmaceutical the world's 24249th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $49.15M | -5.16% |
2023 | $51.82M | -4.05% |
2022 | $54.01M | -28.85% |
2021 | $75.91M | 28.40% |
2020 | $59.12M | -11.64% |
2019 | $66.91M | -2.48% |
2018 | $68.61M | 1.44% |
2017 | $67.64M | 11.65% |
2016 | $60.58M | -14.73% |
2015 | $71.04M | 10.61% |
2014 | $64.23M | -2.58% |
2013 | $65.93M | 12.92% |
2012 | $58.39M | 10.60% |
2011 | $52.80M | -9.58% |
2010 | $58.39M | -26.38% |
2009 | $79.31M | -9.44% |
2008 | $87.59M | -9.55% |
2007 | $96.83M | -23.17% |
2006 | $126.03M | 6.58% |
2005 | $118.24M | 48.17% |
2004 | $79.80M | 11.19% |
2003 | $71.77M | 16.14% |
2002 | $61.80M | -27.64% |
2001 | $85.40M | - |